Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects

Cancer Research

Volumn 65, Issue 17, 2005, Pages 7888-7895

  Baader, Eva ^a   Toloczko, Agnieszka ^a   Fuchs, Uta ^a   Schmid, Irene ^a   Beltinger, Christian ^b   Ehrhardt, Harald ^a   Debatin, Klaus Michael ^b   Jeremias, Irmela ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COMPLEMENTARY DNA; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; QUINAZOLINE; RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UO 126; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HT29 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24744462114     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4278     Document Type: Article

References (20)

1. Kimberley FC, Screaton GR. Following a TRAIL: update on a ligand and its five receptors. Cell Res 2004;14:359-72.
2. Fulda S, Debatin KM. Modulation of TRAIL signaling for cancer therapy. Vitam Horm 2004;67:275-90.
3. Kelley SK, Ashkenazi A. Targeting death receptors in cancer with Apo2L/TRAIL. Curr Opin Pharmacol 2004;4:333-9.
4. Peter ME. The TRAIL DISCussion: it is FADD and caspase-8! Cell Death Differ 2000;7:759-60.
5. Roth W, Reed JC. FLIP protein and TRAIL-induced apoptosis. Vitam Horm 2004;67:189-206.
6. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675-87.
7. Pietro RD, Zauli G. Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L. J Cell Physiol 2004;201:331-40.
8. Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin KM. Inhibition of NFkB activation attenuates apoptosis resistance in lymphoid cells. Blood 1998;91:4624-31.
9. Wajant H. TRAIL and NFκB signaling; a complex relationship. Vitam Horm 2004;67:101-32.
10. Ehrhardt H, Fulda S, Schmid I, Hiscott J, Debatin KM, Jeremias I. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB. Oncogene 2003;22:3842-52.
11. Jeremias I, Herr I, Boehler T, Debatin KM. TRAIL/Apo-2-Ligand induced apoptosis in T-cells. Eur J Immunol 1998;28:143-52.
12. Fulda S, Strauss G, Meyer E, Debatin KM. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells. Blood 2000;95:301-8.
13. Armstrong RC, Aja T, Xiang J, et al. Fas-induced activation of the cell death-related protease CPP32 Is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 1996;271:16850-5.
14. Fulda S, Kufer MU, Meyer E, Van Valen F, Dockhorn-Dworniczak B, Debatin KM. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 2001;20:5865-77.
15. Juo P, Kuo CJ, Yuan J, Blenis J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 1998;8:1001-8.
16. Medema JP, Scaffidi C, Krammer PH, Peter ME. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J Biol Chem 1998;273:3388-93.
17. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21.
18. Grassi F, Piacentini A, Cristino S, Toneguzzi S, Facchini A, Lisignoli G. Inhibition of CD95 apoptotic signaling by interferon-γ in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein. Arthritis Rheum 2004;50:498-506.
19. Wilda M, Fuchs U, Wossmann W, Borkhardt A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 2002;21:5716-24.
20. Wachter T, Sprick M, Hausmann D, et al. cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-κB activation at the death-inducing signaling complex in human keratinocytes. J Biol Chem 2004;279:52824-34.